Former Novartis exec pleads guilty in generics price-fixing conspiracy
Tuesday, February 18, 2020
An industrywide price-fixing probe has snared another former exec—this time a big fish at Novartis' generics business, Sandoz. Hector Armando Kellum, who faces 10 years in prison, agreed to cooperate with the feds, and his plea confirms the Swiss drugmaker's role in the conspiracy.
Post a Comment